SCI时时刷

search
The Blood‐CSF‐Brain Route of Neurological Disease: The Indirect Pathway into the Brain.
The Blood‐CSF‐Brain Route of Neurological Disease: The Indirect Pathway into the Brain.
Abstract The brain is protected by the endothelial blood-brain-barrier (BBB) that limits the access of micro-organisms, tu...
Primary Age‐Related Tauopathy (PART) in a Finnish Population‐Based Study of the Oldest Old (Vantaa 85+)
Primary Age‐Related Tauopathy (PART) in a Finnish Population‐Based Study of the Oldest Old (Vantaa 85+)
Abstract Aims Few studies have investigated primary age-related tauopathy (PART) in a population-based setting. Here we as...
Brain TDP‐43 pathology in corticobasal degeneration: topographical correlation with neuronal loss
Brain TDP‐43 pathology in corticobasal degeneration: topographical correlation with neuronal loss
Abstract Aims Neuronal and glial inclusions comprising transactive response DNA-binding protein of 43 kDa (TDP-43) have be...
Longstanding Multiple System Atrophy‐Parkinsonism with Limbic and FTLD‐type α‐Synuclein Pathology
Longstanding Multiple System Atrophy‐Parkinsonism with Limbic and FTLD‐type α‐Synuclein Pathology
Abstract Multiple system atrophy (MSA) is a sporadic neurodegenerative disease clinically marked by autonomic failure and ...
Automated immunofluorescence analysis for sensitive and precise dystrophin quantification in muscle biopsies
Automated immunofluorescence analysis for sensitive and precise dystrophin quantification in muscle biopsies
Abstract Aims Dystrophin, the protein product of the DMD gene, plays a critical role in muscle integrity by stabilizing th...
The desmin mutation R349P increases contractility and fragility of stem cell‐generated muscle micro‐tissues
The desmin mutation R349P increases contractility and fragility of stem cell‐generated muscle micro‐tissues
Abstract Aims Desminopathies comprise hereditary myopathies and cardiomyopathies caused by mutations in the intermediate f...
AKT1E17K‐mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD5363
AKT1E17K‐mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD5363
Abstract Objectives Meningiomas are the most frequent primary brain tumours. Recently, knowledge about the molecular drive...
Dysfunction of the blood‐brain barrier in Alzheimer’s disease: evidence from human studies
Dysfunction of the blood‐brain barrier in Alzheimer’s disease: evidence from human studies
Abstract The pathological processes leading to synapse loss, neuronal loss, brain atrophy and gliosis in Alzheimer´s ...
Concurrent tau pathologies in frontotemporal lobar degeneration with TDP‐43 pathology
Concurrent tau pathologies in frontotemporal lobar degeneration with TDP‐43 pathology
Abstract Aims Accumulating evidence suggests that patients with frontotemporal lobar degeneration (FTLD) can have patholog...
Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation
Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation
Abstract Aims To illuminate the pathological synergy between Aβ and tau leading to the neurofibrillary tangles (NFT)...
Alpha adaptins show isoform‐specific association with neurofibrillary tangles in Alzheimer’s disease.
Alpha adaptins show isoform‐specific association with neurofibrillary tangles in Alzheimer’s disease.
Abstract Aims The heterotetrameric assembly protein complex 2 (AP-2) is a central hub for clathrin-dependent endocytosis. ...
Non‐coding regulatory elements: potential roles in disease and the case of epilepsy
Non‐coding regulatory elements: potential roles in disease and the case of epilepsy
Abstract Non-coding DNA (ncDNA) refers to the portion of the genome that does not code for proteins and accounts for the g...